Abstract-5,6-Epoxyeicosatrienoic acid (5,6-EET) is a cytochrome P450 epoxygenase metabolite of arachidonic acid that causes vasorelaxation. However, investigations of its role in biological systems have been limited by its chemical instability. We developed a stable agonist of 5,6-EET, 5-(pentadeca-3(Z),6(Z),9(Z)-trienyloxy)pentanoic acid (PTPA), in which the 5,6-epoxide was replaced with a 5-ether. PTPA obviates chemical and enzymatic hydrolysis. In bovine coronary artery rings precontracted with U46619, PTPA (1 nmol/L to 10 mol/L) induced concentration-dependent relaxations, with maximal relaxation of 86Ϯ5% and EC 50 of 1 mol/L. The relaxations were inhibited by the cyclooxygenase inhibitor indomethacin (10 mol/L; max relaxation 43Ϯ9%); the ATP-sensitive K ϩ channel inhibitor glybenclamide (10 mol/L; max relaxation 49Ϯ6%); and the large conductance calcium-activated K ϩ channel inhibitor iberiotoxin (100 nmol/L; max relaxation 38Ϯ6%) and abolished by the combination of iberiotoxin with indomethacin or glybenclamide or increasing extracellular K ϩ to 20 mmol/L. Whole-cell outward K ϩ current was increased nearly 6-fold by PTPA (10 mol/L), which was also blocked by iberiotoxin. Additionally, we synthesized 5-(pentadeca-6(Z),9(Z)-dienyloxy)pentanoic acid and 5-(pentadeca-3(Z),9(Z)-dienyloxy)pentanoic acid (PDPA), PTPA analogs that lack the 8,9 or 11,12 double bonds of arachidonic acid and therefore are not substrates for cyclooxygenase. The PDPAs caused concentration-dependent relaxations (max relaxations 46Ϯ13% and 52Ϯ7%, respectively; EC 50 1mol/L), which were not altered by glybenclamide but blocked by iberiotoxin. These studies suggested that PTPA induces relaxation through 2 mechanisms: (1) cyclooxygenase-dependent metabolism to 5-ether-containing prostaglandins that activate ATP-sensitive K ϩ channels and (2) Key Words: arachidonic acids Ⅲ cyclooxygenase Ⅲ endothelium-derived factors C ytochrome P450 epoxygenases metabolize arachidonic acid to 4 regioisomeric epoxyeicosatrienoic acids (EETs): 14,15-EET, 11,12-EET, 8,9-EET, and 5,6-EET. 1 The EETs have a range of biological activities including vasodilation, 2,3 release of catecholamines 4 and hypothalamic hormones, 5 and alteration of sodium transport. 6 In some instances, the 4 EET regioisomers are equipotent in biological activity, 2 and in other instances, a particular regioisomer is active, whereas other isomers are inactive or less active. 7 EETs are metabolized by soluble epoxide hydrolase to dihydroxyeicosatrienoic acids (DHETs) 8 by -oxidation to short-chain epoxides 9 or by incorporation into membrane phospholipids. 10 These pathways represent mechanisms of cellular inactivation and EET recycling. With the exception of 5,6-EET, the EETs are chemically stable in alkaline aqueous solution. 5,6-EET is hydrolyzed to 5,6-DHET and its ␦-lactone under neutral and acidic conditions. 11,12 In some studies, the methyl ester of 5,6-EET is used because of its improved chemical stability. The chemical instability has limited investigation of this EET regioiso...